Systems-Based Analyses of Brain Regions Functionally Impacted in Parkinson's Disease Reveals Underlying Causal Mechanisms
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
Detailed analysis of disease-affected tissue provides insight into molecular mechanisms contributing to pathogenesis. Substantia nigra, striatum, and cortex are functionally connected with increasing degrees of alpha-synuclein pathology in Parkinson's disease. We undertook functional and causal pathway analysis of gene expression and proteomic alterations in these three regions, and the data revealed pathways that correlated with disease progression. In addition, microarray and RNAseq experiments revealed previously unidentified causal changes related to oligodendrocyte function and synaptic vesicle release, and these and other changes were reflected across all brain regions. Importantly, subsets of these changes were replicated in Parkinson's disease blood; suggesting peripheral tissue may provide important avenues for understanding and measuring disease status and progression. Proteomic assessment revealed alterations in mitochondria and vesicular transport proteins that preceded gene expression changes indicating defects in translation and/or protein turnover. Our combined approach of proteomics, RNAseq and microarray analyses provides a comprehensive view of the molecular changes that accompany functional loss and alpha-synuclein pathology in Parkinson's disease, and may be instrumental to understand, diagnose and follow Parkinson's disease progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global quantification of mammalian gene expression control
Schwanhäusser, B., Busse, D., Li, N., Dittmar, G., Schuchhardt, J., Wolf, J., Chen, W., & Selbach, M. (2011) · Nature · doi:10.1038/nature10098 · Cited by 6,566
DEGseq: an R package for identifying differentially expressed genes from RNA-seq data
Wang, L., Feng, Z., Wang, X., Wang, X., & Zhang, X. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp612 · Cited by 4,553
Stages in the development of Parkinson’s disease-related pathology
Braak, H., Ghebremedhin, E., Rüb, U., Bratzke, H., & Del Tredici, K. (2004) · Cell and Tissue Research · doi:10.1007/s00441-004-0956-9 · Cited by 2,689 · cited 3×
“While the mechanisms underlying PD initiation and progression still remains a mystery, PDrelated pathology and its progressive spread, initially described by Braak [5] [6], are a hallmark of pathogenesis.”
BackgroundGlobal signatures of protein and mRNA expression levels
de Sousa Abreu, R., Penalva, L. O., Marcotte, E. M., & Vogel, C. (2009) · Molecular BioSystems · doi:10.1039/b908315d · Cited by 1,248
Arizona Parkinson’s Disease Consortium, Beach, T. G., Adler, C. H., Sue, L. I., Vedders, L., Lue, L., White III, C. L., Akiyama, H., Caviness, J. N., Shill, H. A., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0664-3 · Cited by 911
Comparative analysis of proteome and transcriptome variation in mouse
Ghazalpour, A., Bennett, B., Petyuk, V. A., Orozco, L., Hagopian, R., Mungrue, I. N., Farber, C. R., Sinsheimer, J., Kang, H. M., Furlotte, N., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1001393 · Cited by 624
Variation and genetic control of protein abundance in humans
Wu, L., Candille, S. I., Choi, Y., Xie, D., Jiang, L., Li-Pook-Than, J., Tang, H., & Snyder, M. (2013) · Nature · doi:10.1038/nature12223 · Cited by 364
Genes, behavior and next‐generation RNA sequencing
Hitzemann, R., Bottomly, D., Darakjian, P., Walter, N., Iancu, O., Searles, R., Wilmot, B., & McWeeney, S. (2013) · Genes, Brain and Behavior · doi:10.1111/gbb.12007 · Cited by 88
Research works printed but not linked: 65
- JC Rochet, 2012, Molecular insights into Parkinson's disease, Prog Mol Biol Transl Sci, 107, 125, 10.1016/B978-0-12-385883-2.00011-4 · DOI
- MI Shadrina, 2010, Molecular mechanisms of pathogenesis of Parkinson's disease, Int Rev Cell Mol Biol, 281, 229, 10.1016/S1937-6448(10)81006-8 · DOI
- S Lesage, 2009, Parkinson's disease: from monogenic forms to genetic susceptibility factors, Hum Mol Genet, 18, R48, 10.1093/hmg/ddp012 · DOI · Paper page
- AH Schapira, 2011, Etiology and pathogenesis of Parkinson's disease, Mov Disord, 26, 1049, 10.1002/mds.23732 · DOI · Paper page
- H Braak, 2003, Staging of brain pathology related to sporadic Parkinson's disease, Neurobiol Aging, 24, 197, 10.1016/S0197-4580(02)00065-9 · DOI · Paper page
- MG Cersosimo, 2011, Alpha-synuclein immunoreactivity in minor salivary gland biopsies of Parkinson's disease patients, Mov Disord, 26, 188, 10.1002/mds.23344 · DOI
- K Del Tredici, 2010, Lewy pathology in the submandibular gland of individuals with incidental Lewy body disease and sporadic Parkinson's disease, Acta Neuropathol, 119, 703, 10.1007/s00401-010-0665-2 · DOI · Paper page
- I Devic, 2011, Salivary alpha-synuclein and DJ-1: potential biomarkers for Parkinson's disease, Brain, 134, e178, 10.1093/brain/awr015 · DOI · Paper page
- KT Olde Dubbelink, 2014, Disrupted brain network topology in Parkinson's disease: a longitudinal magnetoencephalography study, Brain, 137, 197, 10.1093/brain/awt316 · DOI · Paper page
- MM Ponsen, 2012, A three dimensional anatomical view of oscillatory resting-state activity and functional connectivity in Parkinson's disease related dementia: An MEG study using atlas-based beamforming, Neuroimage Clin, 2, 95, 10.1016/j.nicl.2012.11.007 · DOI
- P Hickey, 2011, Available and emerging treatments for Parkinson's disease: a review, Drug Des Devel Ther, 5, 241
- WM Caudle, 2010, Using ‘omics’ to define pathogenesis and biomarkers of Parkinson's disease, Expert Rev Neurother, 10, 925, 10.1586/ern.10.54 · DOI
- PA Lewis, 2012, Gene expression in the Parkinson's disease brain, Brain Res Bull, 88, 302, 10.1016/j.brainresbull.2011.11.016 · DOI
- N Pankratz, 2012, Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2, Ann Neurol, 71, 370, 10.1002/ana.22687 · DOI · Paper page
- A Vellaichamy, 2010, “Topological significance” analysis of gene expression and proteomic profiles from prostate cancer cells reveals key mechanisms of androgen response, PLoS One, 5, e10936, 10.1371/journal.pone.0010936 · DOI
- S Jaeger, 2014, Causal Network Models for Predicting Compound Targets and Driving Pathways in Cancer, J Biomol Screen
- C Su, 2013, Using Bayesian networks to discover relations between genes, environment, and disease, BioData Min, 6, 6, 10.1186/1756-0381-6-6 · DOI
- C Taccioli, 2011, ParkDB: a Parkinson's disease gene expression database, Database (Oxford), 2011, bar007, 10.1093/database/bar007 · DOI
- D Bottomly, 2011, Evaluating gene expression in C57BL/6J and DBA/2J mouse striatum using RNA-Seq and microarrays, PLoS One, 6, e17820, 10.1371/journal.pone.0017820 · DOI · Paper page
- M Mooney, 2013, Comparative RNA-Seq and microarray analysis of gene expression changes in B-cell lymphomas of Canis familiaris, PLoS One, 8, e61088, 10.1371/journal.pone.0061088 · DOI
- JM Shoffner, 1991, Mitochondrial oxidative phosphorylation defects in Parkinson's disease, Ann Neurol, 30, 332, 10.1002/ana.410300304 · DOI · Paper page
- C Perier, 2012, Mitochondrial biology and Parkinson's disease, Cold Spring Harb Perspect Med, 2, a009332, 10.1101/cshperspect.a009332 · DOI · Paper page
- SJ Gardai, 2013, Elevated Alpha-Synuclein Impairs Innate Immune Cell Function and Provides a Potential Peripheral Biomarker for Parkinson's Disease, Plos One, e71634, 10.1371/journal.pone.0071634 · DOI · Paper page
- YJ Edwards, 2011, Identifying consensus disease pathways in Parkinson's disease using an integrative systems biology approach, PLoS One, 6, e16917, 10.1371/journal.pone.0016917 · DOI
- GT Sutherland, 2009, A cross-study transcriptional analysis of Parkinson's disease, PLoS One, 4, e4955, 10.1371/journal.pone.0004955 · DOI · Paper page
- A Dumitriu, 2012, Gene expression profiles in Parkinson disease prefrontal cortex implicate FOXO1 and genes under its transcriptional regulation, PLoS Genet, 8, e1002794, 10.1371/journal.pgen.1002794 · DOI · Paper page
- P Carbonetto, 2013, Integrated enrichment analysis of variants and pathways in genome-wide association studies indicates central role for IL-2 signaling genes in type 1 diabetes, and cytokine signaling genes in Crohn's disease, PLoS Genet, 9, e1003770, 10.1371/journal.pgen.1003770 · DOI
- VK Mootha, 2003, PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes, Nat Genet, 34, 267, 10.1038/ng1180 · DOI · Paper page
- DJ Wong, 2005, Learning more from microarrays: insights from modules and networks, J Invest Dermatol, 125, 175, 10.1111/j.0022-202X.2005.23827.x · DOI
- YA Kim, 2011, Identifying causal genes and dysregulated pathways in complex diseases, PLoS Comput Biol, 7, e1001095, 10.1371/journal.pcbi.1001095 · DOI · Paper page
- LB Moran, 2006, Whole genome expression profiling of the medial and lateral substantia nigra in Parkinson's disease, Neurogenetics, 7, 1, 10.1007/s10048-005-0020-2 · DOI · Paper page
- O Myhre, 2013, Metal Dyshomeostasis and Inflammation in Alzheimer's and Parkinson's Diseases: Possible Impact of Environmental Exposures, Oxidative Medicine and Cellular Longevity, 2013, 10.1155/2013/726954 · DOI · Paper page
- M Cesani, 2014, Metallothioneins as dynamic markers for brain disease in lysosomal disorders, Ann Neurol, 75, 127, 10.1002/ana.24053 · DOI
- T Shachar, 2011, Lysosomal storage disorders and Parkinson's disease: Gaucher disease and beyond, Mov Disord, 26, 1593, 10.1002/mds.23774 · DOI · Paper page
- T Hattori, 2012, Cognitive status correlates with white matter alteration in Parkinson's disease, Hum Brain Mapp, 33, 727, 10.1002/hbm.21245 · DOI · Paper page
- CL Rae, 2012, White matter pathology in Parkinson's disease: the effect of imaging protocol differences and relevance to executive function, Neuroimage, 62, 1675, 10.1016/j.neuroimage.2012.06.012 · DOI · Paper page
- N Fabelo, 2011, Severe alterations in lipid composition of frontal cortex lipid rafts from Parkinson's disease and incidental Parkinson's disease, Mol Med, 17, 1107, 10.2119/molmed.2011.00119 · DOI · Paper page
- A Koppelkamm, 2011, RNA integrity in post-mortem samples: influencing parameters and implications on RT-qPCR assays, Int J Legal Med, 125, 573, 10.1007/s00414-011-0578-1 · DOI
- JA Obeso, 2010, Missing pieces in the Parkinson's disease puzzle, Nat Med, 16, 653, 10.1038/nm.2165 · DOI · Paper page
- M Basso, 2004, Proteome analysis of human substantia nigra in Parkinson's disease, Proteomics, 4, 3943, 10.1002/pmic.200400848 · DOI · Paper page
- V Licker, 2012, Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease, J Proteomics, 75, 4656, 10.1016/j.jprot.2012.02.032 · DOI
- CJ Werner, 2008, Proteome analysis of human substantia nigra in Parkinson's disease, Proteome Sci, 6, 8, 10.1186/1477-5956-6-8 · DOI · Paper page
- B Schwanhausser, 2013, Corrigendum: Global quantification of mammalian gene expression control, Nature, 495, 126, 10.1038/nature11848 · DOI · Paper page
- MC Chartier-Harlin, 2011, Translation initiator EIF4G1 mutations in familial Parkinson disease, Am J Hum Genet, 89, 398, 10.1016/j.ajhg.2011.08.009 · DOI · Paper page
- J Jin, 2007, Identification of novel proteins associated with both alpha-synuclein and DJ-1, Mol Cell Proteomics, 6, 845, 10.1074/mcp.M600182-MCP200 · DOI · Paper page
- F Kthiri, 2010, Translational defects in a mutant deficient in YajL, the bacterial homolog of the parkinsonism-associated protein DJ-1, J Bacteriol, 192, 6302, 10.1128/JB.01077-10 · DOI
- J Trinh, 2013, Advances in the genetics of Parkinson disease, Nat Rev Neurol, 9, 445, 10.1038/nrneurol.2013.132 · DOI · Paper page
- Y Zhang, 2005, Transcriptional analysis of multiple brain regions in Parkinson's disease supports the involvement of specific protein processing, energy metabolism, and signaling pathways, and suggests novel disease mechanisms, Am J Med Genet B Neuropsychiatr Genet, 137B, 5, 10.1002/ajmg.b.30195 · DOI · Paper page
- F Blandini, 2003, Peripheral markers of apoptosis in Parkinson's disease: the effect of dopaminergic drugs, Ann N Y Acad Sci, 1010, 675, 10.1196/annals.1299.123 · DOI · Paper page
- PV Bondarenko, 2002, Identification and relative quantitation of protein mixtures by enzymatic digestion followed by capillary reversed-phase liquid chromatography-tandem mass spectrometry, Anal Chem, 74, 4741, 10.1021/ac0256991 · DOI · Paper page
- AM Falick, 2011, ABRF-PRG07: advanced quantitative proteomics study, J Biomol Tech, 22, 21
- Z Khan, 2009, Protein quantification across hundreds of experimental conditions, Proc Natl Acad Sci U S A, 106, 15544, 10.1073/pnas.0904100106 · DOI · Paper page
- W Wang, 2003, Quantification of proteins and metabolites by mass spectrometry without isotopic labeling or spiked standards, Anal Chem, 75, 4818, 10.1021/ac026468x · DOI · Paper page
- R Edgar, 2002, Gene Expression Omnibus: NCBI gene expression and hybridization array data repository, Nucleic Acids Res, 30, 207, 10.1093/nar/30.1.207 · DOI · Paper page
- RA Irizarry, 2003, Exploration, normalization, and summaries of high density oligonucleotide array probe level data, Biostatistics, 4, 249, 10.1093/biostatistics/4.2.249 · DOI · Paper page
- J Zhang, 2005, Detecting false expression signals in high-density oligonucleotide arrays by an in silico approach, Genomics, 85, 297, 10.1016/j.ygeno.2004.11.004 · DOI
- WE Johnson, 2007, Adjusting batch effects in microarray expression data using empirical Bayes methods, Biostatistics, 8, 118, 10.1093/biostatistics/kxj037 · DOI · Paper page
- GK Smyth, 2004, Linear models and empirical bayes methods for assessing differential expression in microarray experiments, Stat Appl Genet Mol Biol, 3, Article3, 10.2202/1544-6115.1027 · DOI · Paper page
- B Li, 2011, RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome, BMC Bioinformatics, 12, 323, 10.1186/1471-2105-12-323 · DOI · Paper page
- W Huang da, 2007, DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists, Nucleic Acids Res, 35, W169, 10.1093/nar/gkm415 · DOI · Paper page
- S Bureeva, 2009, Manual annotation of protein interactions, Methods Mol Biol, 563, 75, 10.1007/978-1-60761-175-2_5 · doi:10.1007/978-1-60761-175-2_5
- M Ashburner, 2000, Gene ontology: tool for the unification of biology. The Gene Ontology Consortium, Nat Genet, 25, 25, 10.1038/75556 · DOI · Paper page
- M Bessarabova, 2012, Knowledge-based analysis of proteomics data, BMC Bioinformatics, 13 Suppl 16, S13, 10.1186/1471-2105-13-S16-S13 · DOI
- Z Dezso, 2009, Identifying disease-specific genes based on their topological significance in protein networks, BMC Syst Biol, 3, 36, 10.1186/1752-0509-3-36 · DOI
- C Gene Ontology, 2010, The Gene Ontology in 2010: extensions and refinements, Nucleic Acids Res, 38, D331, 10.1093/nar/gkp1018 · DOI · Paper page
Cited by
An environment-dependent transcriptional network specifies human microglia identity
Gosselin, D., Skola, D., Coufal, N. G., Holtman, I. R., Schlachetzki, J. C. M., Sajti, E., Jaeger, B. N., O’Connor, C., Fitzpatrick, C., Pasillas, M. P., et al. (2017) · Science · doi:10.1126/science.aal3222 · Cited by 1,220
“or down-regulated in PD in cortex (51),”
Das, S., Li, Z., Noori, A., Hyman, B. T., & Serrano-Pozo, A. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01898-y · Cited by 80
Taymans, J.-M., Nkiliza, A., & Chartier-Harlin, M.-C. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.05.004 · Cited by 50
Metadata
- Authors
- Riley, B. E., Gardai, S. J., Emig-Agius, D., Bessarabova, M., Ivliev, A. E., Schüle, B., Alexander, J., Wallace, W., Halliday, G. M., Langston, J. W., Braxton, S., Yednock, T., Shaler, T., & Johnston, J. A.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-08-29
- Volume
- 9
- Issue
- 8
- Pages
- e102909
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2067865628
- Cited by
- 86
- References
- 8
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Update notices
- correction (2014-12-01)
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systems-Based Analyses of Brain Regions Functionally Impacted in Parkinson's Disease Reveals Underlying Causal Mechanisms. https://app.cochat.ai/papers/10.1371/journal.pone.0102909
- The paper
- Riley, B. E., Gardai, S. J., Emig-Agius, D., Bessarabova, M., Ivliev, A. E., Schüle, B., Alexander, J., Wallace, W., Halliday, G. M., Langston, J. W., Braxton, S., Yednock, T., Shaler, T., & Johnston, J. A. (2014). Systems-Based Analyses of Brain Regions Functionally Impacted in Parkinson's Disease Reveals Underlying Causal Mechanisms. PLoS ONE. https://doi.org/10.1371/journal.pone.0102909
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.